Catalyst Wire Dossier Catalyst Wire Dossier

OXN PR

Oxycodone/naloxone prolonged-release · Mundipharma Oy
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for OXN PR, covering 2012-02-16 to 2018-10-23. Get the full timeline:

Most recent: Clinical Trial Update: OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS) [Phase 2]

See pricing